You are here

  • Home
  • Archive
  • Volume 6, Issue 3
  • Interferon β-1a prevented the development of clinically definite multiple sclerosis after a first demyelinating event

Article Text

Article menu
Download PDFPDF
Therapeutics
Interferon β-1a prevented the development of clinically definite multiple sclerosis after a first demyelinating event

https://doi.org/10.1136/ebm.6.3.78

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Source of funding: Biogen.

    • For correspondence: Dr L D Jacobs, Department of Neurology, Buffalo General Hospital, 100 High Street, Buffalo, NY 14203, USA. Fax +1 716 859 2430.

    • ↵* See glossary.

    • ↵† Information provided by author.